These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27332149)

  • 1. Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus.
    Payne DC; Iblan I; Rha B; Alqasrawi S; Haddadin A; Al Nsour M; Alsanouri T; Ali SS; Harcourt J; Miao C; Tamin A; Gerber SI; Haynes LM; Al Abdallat MM
    Emerg Infect Dis; 2016 Oct; 22(10):1824-6. PubMed ID: 27332149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hospital-associated outbreak of Middle East respiratory syndrome coronavirus: a serologic, epidemiologic, and clinical description.
    Al-Abdallat MM; Payne DC; Alqasrawi S; Rha B; Tohme RA; Abedi GR; Al Nsour M; Iblan I; Jarour N; Farag NH; Haddadin A; Al-Sanouri T; Tamin A; Harcourt JL; Kuhar DT; Swerdlow DL; Erdman DD; Pallansch MA; Haynes LM; Gerber SI;
    Clin Infect Dis; 2014 Nov; 59(9):1225-33. PubMed ID: 24829216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serologic Detection of Middle East Respiratory Syndrome Coronavirus Functional Antibodies.
    Okba NMA; Widjaja I; Li W; GeurtsvanKessel CH; Farag EABA; Al-Hajri M; Park WB; Oh MD; Reusken CBEM; Koopmans MPG; Bosch BJ; Haagmans BL
    Emerg Infect Dis; 2020 May; 26(5):1024-1027. PubMed ID: 32150528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitive and Specific Detection of Low-Level Antibody Responses in Mild Middle East Respiratory Syndrome Coronavirus Infections.
    Okba NMA; Raj VS; Widjaja I; GeurtsvanKessel CH; de Bruin E; Chandler FD; Park WB; Kim NJ; Farag EABA; Al-Hajri M; Bosch BJ; Oh MD; Koopmans MPG; Reusken CBEM; Haagmans BL
    Emerg Infect Dis; 2019 Oct; 25(10):1868-1877. PubMed ID: 31423970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015.
    Choe PG; Perera RAPM; Park WB; Song KH; Bang JH; Kim ES; Kim HB; Ko LWR; Park SW; Kim NJ; Lau EHY; Poon LLM; Peiris M; Oh MD
    Emerg Infect Dis; 2017 Jul; 23(7):1079-1084. PubMed ID: 28585916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of MERS coronavirus neutralizing antibodies in humans, eastern province, Saudi Arabia.
    Gierer S; Hofmann-Winkler H; Albuali WH; Bertram S; Al-Rubaish AM; Yousef AA; Al-Nafaie AN; Al-Ali AK; Obeid OE; Alkharsah KR; Pöhlmann S
    Emerg Infect Dis; 2013 Dec; 19(12):2034-6. PubMed ID: 24274664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental Infection and Response to Rechallenge of Alpacas with Middle East Respiratory Syndrome Coronavirus.
    Crameri G; Durr PA; Klein R; Foord A; Yu M; Riddell S; Haining J; Johnson D; Hemida MG; Barr J; Peiris M; Middleton D; Wang LF
    Emerg Infect Dis; 2016 Jun; 22(6):1071-4. PubMed ID: 27070733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MERS coronavirus neutralizing antibodies in camels, Eastern Africa, 1983-1997.
    Müller MA; Corman VM; Jores J; Meyer B; Younan M; Liljander A; Bosch BJ; Lattwein E; Hilali M; Musa BE; Bornstein S; Drosten C
    Emerg Infect Dis; 2014 Dec; 20(12):2093-5. PubMed ID: 25425139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient.
    Niu P; Zhang S; Zhou P; Huang B; Deng Y; Qin K; Wang P; Wang W; Wang X; Zhou J; Zhang L; Tan W
    J Infect Dis; 2018 Sep; 218(8):1249-1260. PubMed ID: 29846635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectivity of an Asymptomatic Patient With Middle East Respiratory Syndrome Coronavirus Infection.
    Moon SY; Son JS
    Clin Infect Dis; 2017 May; 64(10):1457-1458. PubMed ID: 28444154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) antibodies in dromedary camels in Israel.
    Harcourt JL; Rudoler N; Tamin A; Leshem E; Rasis M; Giladi M; Haynes LM
    Zoonoses Public Health; 2018 Sep; 65(6):749-754. PubMed ID: 29855166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections.
    Ying T; Li H; Lu L; Dimitrov DS; Jiang S
    Microbes Infect; 2015 Feb; 17(2):142-8. PubMed ID: 25456101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human neutralizing antibodies against MERS coronavirus: implications for future immunotherapy.
    Tang XC; Marasco WA
    Immunotherapy; 2015; 7(6):591-4. PubMed ID: 26098703
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetics of Serologic Responses to MERS Coronavirus Infection in Humans, South Korea.
    Park WB; Perera RA; Choe PG; Lau EH; Choi SJ; Chun JY; Oh HS; Song KH; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Man Poon LL; Peiris M; Oh MD
    Emerg Infect Dis; 2015 Dec; 21(12):2186-9. PubMed ID: 26583829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013.
    Reusken CB; Ababneh M; Raj VS; Meyer B; Eljarah A; Abutarbush S; Godeke GJ; Bestebroer TM; Zutt I; Muller MA; Bosch BJ; Rottier PJ; Osterhaus AD; Drosten C; Haagmans BL; Koopmans MP
    Euro Surveill; 2013 Dec; 18(50):20662. PubMed ID: 24342516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MERS-CoV Antibodies in Humans, Africa, 2013-2014.
    Liljander A; Meyer B; Jores J; Müller MA; Lattwein E; Njeru I; Bett B; Drosten C; Corman VM
    Emerg Infect Dis; 2016 Jun; 22(6):1086-9. PubMed ID: 27071076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
    Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Serologic Assays for Middle East Respiratory Syndrome Coronavirus.
    Harvey R; Mattiuzzo G; Hassall M; Sieberg A; Müller MA; Drosten C; Rigsby P; Oxenford CJ;
    Emerg Infect Dis; 2019 Oct; 25(10):1878-1883. PubMed ID: 31423969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Middle East Respiratory Syndrome Coronavirus Infection Dynamics and Antibody Responses among Clinically Diverse Patients, Saudi Arabia.
    Al-Abdely HM; Midgley CM; Alkhamis AM; Abedi GR; Lu X; Binder AM; Alanazi KH; Tamin A; Banjar WM; Lester S; Abdalla O; Dahl RM; Mohammed M; Trivedi S; Algarni HS; Sakthivel SK; Algwizani A; Bafaqeeh F; Alzahrani A; Alsharef AA; Alhakeem RF; Jokhdar HAA; Ghazal SS; Thornburg NJ; Erdman DD; Assiri AM; Watson JT; Gerber SI
    Emerg Infect Dis; 2019 Apr; 25(4):753-766. PubMed ID: 30882305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant Spike-Specific IgG and Neutralizing Antibodies in Mice Induced by a Novel Chimeric Virus-Like Particle Vaccine Candidate for Middle East Respiratory Syndrome Coronavirus.
    Lan J; Deng Y; Song J; Huang B; Wang W; Tan W
    Virol Sin; 2018 Oct; 33(5):453-455. PubMed ID: 30374826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.